Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 12;8(4):00232-2022.
doi: 10.1183/23120541.00232-2022. eCollection 2022 Oct.

The demographics, clinical characteristics and quality of life of patients with chronic cough from the Isala Cough Clinic in the Netherlands

Affiliations

The demographics, clinical characteristics and quality of life of patients with chronic cough from the Isala Cough Clinic in the Netherlands

Jan Willem K van den Berg et al. ERJ Open Res. .

Abstract

Introduction: Chronic cough affects ∼10% of the population and adversely impacts quality of life. This retrospective observational cohort study aimed to identify the demographics, clinical characteristics and quality of life of the chronic cough population in a Dutch chronic cough clinic, at baseline and following treatment at 6 months. Patients were categorised based on the underlying phenotype and response to treatment.

Methods: Retrospective data on 2397 patients who were diagnosed according to standard guidelines of the American College of Chest Physicians were analysed. Quality of life was captured via the Leicester Cough Questionnaire, the Cough Numeric Rating Scale and the Hospital Anxiety and Depression Scale.

Results: Mean patient age was 59 years; 62.5% of the patients were female; and 69.1% had at least one underlying phenotype associated with chronic cough. Of the latter, 52.1% had bronchial hyperresponsiveness/airflow limitation, 33.3% had airway reflux and 20.1% had upper airway cough syndrome. 46% of patients with a phenotype, and 51% without, experienced no improvement in their quality of life or still had significant cough remaining after 6 months. Of patients with available quality-of-life data, 37.5% were categorised as having refractory chronic cough, and 9.5% were categorised as unexplained chronic cough.

Discussion: This study highlights the poor quality-of-life outcomes in patients with chronic cough, despite interventions to treat underlying conditions, and indicates a need to manage chronic cough irrespective of phenotype.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: J.W.K. van den Berg participates on a data safety monitoring board or advisory board at GlaxoSmithKline PLC, Chiesi Ltd, Novartis AG and Merck & Co., Inc., Rahway, NJ, USA. Conflict of interest: C.A. Baxter is a full-time employee of MSD (UK) Limited, London, UK, and shareholder of Merck & Co., Inc., Rahway, NJ, USA. Conflict of interest: M.A. Edens has nothing to disclose. Conflict of interest: K.W. Patberg has nothing to disclose. Conflict of interest: H. van der Velden is a full-time employee of MSD BV, The Netherlands. Conflict of interest: A. Weijerse is a full-time employee of MSD BV, The Netherlands, and shareholder of Merck & Co., Inc., Rahway, NJ, USA. Conflict of interest: S. Salomonsson is a full-time employee of MSD Sweden, and shareholder of Merck & Co., Inc., Rahway, NJ, USA.

Figures

FIGURE 1
FIGURE 1
Correlation between patient improvement and Leicester Cough Questionnaire (LCQ) and the Cough Numeric Rating Scale (NRS-cough). a) Change (Δ) LCQ (n=806), mean±sd 2.6±2.9, median (range) 2.4 (0.6–0.4); b) Δ NRS-cough (n=1734), mean±sd −1.7±2.3, median (range) −2.0 (−4.0–0.0); c) the correlation of baseline LCQ with Δ LCQ; d) the correlation of baseline NRS-cough with Δ NRS-cough.
FIGURE 2
FIGURE 2
Flow chart showing the categorisation of patients as refractory chronic cough (RCC) or unexplained chronic cough (UCC). MCID: minimal clinically important difference; LCQ: Leicester Cough Questionnaire; NRS-cough: Cough Numeric Rating Scale.

References

    1. Morice AH, Millqvist E, Bieksiene K, et al. . ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2020; 55: 1901136. doi:10.1183/13993003.01136-2019 - DOI - PMC - PubMed
    1. Song W-J, Chang Y-S, Faruqi S, et al. . The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J 2015; 45: 1479–1481. doi:10.1183/09031936.00218714 - DOI - PubMed
    1. Çolak Y, Nordestgaard BG, Laursen LC, et al. . Risk factors for chronic cough among 14,669 individuals from the general population. Chest 2017; 152: 563–573. doi:10.1016/j.chest.2017.05.038 - DOI - PubMed
    1. Morice AH, Jakes AD, Faruqi S, et al. . A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J 2014; 44: 1149–1155. doi:10.1183/09031936.00217813 - DOI - PubMed
    1. Good JT Jr, Rollins DR, Kolakowski CA, et al. . New insights in the diagnosis of chronic refractory cough. Respir Med 2018; 141: 103–110. doi:10.1016/j.rmed.2018.06.024 - DOI - PubMed

LinkOut - more resources